Ann Okpara
Nurse Practitioner · Everett, WANPI 1811365299
Payments from drug & device makers
Across 36 payments — averaging $28.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- 180 Medical, Inc.$351
- Progenics Pharmaceuticals, Inc.$120
- C. R. Bard, Inc. & Subsidiaries$120
- Convatec Inc.$117
- Urogen Pharma, Inc.$91
- Accord Healthcare, Inc.$63
- plus $155 from 6 others
What the payments were for
- Food & beverage$1,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| 180 Medical, Inc. | 14 | $351 |
| Progenics Pharmaceuticals, Inc. | 5 | $120 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $120 |
| Convatec Inc. | 3 | $117 |
| Urogen Pharma, Inc. | 1 | $91 |
| Accord Healthcare, Inc. | 3 | $63 |
| Telix Pharmaceuticals | 1 | $37 |
| Boston Scientific | 1 | $32 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Immunitybio, Inc. | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| Urovant Sciences Inc | 1 | $16 |
How this compares
$1,017 in reported general payments places this provider in the 85th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 141 | $110,048 |
| GemtesaVibegron | 127 | $76,556 |
| EstringEstradiol | 17 | $8,917 |
| Estradiol | 72 | $7,929 |
| Tamsulosin Hcl | 183 | $3,197 |
| Methenamine Hippurate | 26 | $2,604 |
| Solifenacin Succinate | 70 | $2,370 |
| Trospium Chloride | 32 | $1,648 |
| Cefdinir | 82 | $1,316 |
| Oxybutynin Chloride ErOxybutynin Chloride | 51 | $1,197 |
| Fosfomycin Tromethamine | 11 | $1,190 |
| Finasteride | 67 | $956 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 38 | $728 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $469 |
| Fluconazole | 39 | $314 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Everett
- Kristina BraatenEverett$6K
- Darla ChapmanSeattle$541K
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Wayne ClarkYakima$232K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.